Effects of amifostine on glycerol-pretreated rabbit kidneys

Basic and Clinical Pharmacology and Toxicology

Volumn 97, Issue 3, 2005, Pages 168-173

  Barun, Süreyya ^a   Ertoy, Dilek ^b   Dileköz, Ergin ^a   Müftüoǧlu, Sevda ^b   Erten, Yasemin ^a   Sucak, Gülsan ^a   Bali, Musa ^a   Tekeli, Nurçin ^a   Sarioǧlu, Yusuf ^a   Ercan, Zeynep Sevim ^a  

^a GAZI UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMIFOSTINE; FREE RADICAL; GLYCEROL; PHENYLEPHRINE; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; KIDNEY PERFUSION; MALE; MYOGLOBINURIA; NEPHROTOXICITY; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RABBIT; RENAL PROTECTION; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; AMIFOSTINE; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLYCEROL; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; PERFUSION; RABBITS; RENAL ARTERY; VASODILATION; VASODILATOR AGENTS;

ORYCTOLAGUS CUNICULUS;

EID: 24744452156     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto_97389.x     Document Type: Article

References (51)

1. Baliga, R., N. Ueda, P. D. Walker & S. V. Shah: Oxidant mechanisms in toxic acute renal failure. Amer. J. Kidney Dis. 1997, 29, 467-477.
2. Bywaters, E. G. & D. Beall: Crash injuries with impairment of renal function. J. Amer. Soc. Nephrol. 1998, 9, 322-332.
3. Capizzi R. L.: Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: Laboratory and clinical aspects. Semin. Oncol. 1999, 26, 72-81.
4. Cairns, H. S., L. D. Fairbanks, J. Westwick & G. H. Neild: Cyclosporin therapy in vivo attenuates the response to vasodilators in the isolated perfused kidney of the rabbit. Brit. J. Pharmacol. 1989, 98, 463-468.
5. Carroll, R., K. Kovacs & E. Tapp: The pathogenesis of glycerol-induced renal tubular necrosis. J. Path. Bact. 1965, 61, 573-580.
6. Cassatt, D. R., C. A. Fazenbaker, C. M. Bachy & M. S. Hanson: Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy. Semin. Radiat. Oncol. 2002, 12, 97-102.
7. Cassatt, D. R., C. A. Fazenbaker, G. Kifle & C. M. Bachy: Subcutaneus administration of amifostine (ethyol) is equivalent to intravenous administration in a rat mucositis model. Int. J. Radiat. Oncol. Biol. Phys. 2003, 57, 794-802.
8. Conklin, D. J. & P. J. Boor: Allylamine cardiovascular toxicity: evidence for aberrant vasoreactivity in rats. Toxicol. Appl. Pharmacol. 1998, 148, 245-251.
9. Conklin, D. J., C. L. Boyce, M. B. Trent & P. J. Poor: Amine metabolism: a novel path to coronary artery vasospasm. Toxicol. Appl. Pharmacol. 2001, 175, 149-159.
10. Denu, J. M. & K. G. Tanner: Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 1998, 37, 5633-5642.
11. Douglas, S. A., C. J. Bowmer & M. S. Yates: Vascular smooth muscle function in rats with acute renal failure. J. Pharm. Pharmacol. 1989, 41, 541-544.
12. Durand, R. E., Radioprotection by WR-2721 in-vitro at low oxygen tensions: implications for its mechanisms of action. Brit. J. Cancer 1983, 47, 387-392.
13. Eich, R. F., T. Li, D. D. Lemon, D. H. Doherty, S. R. Curry, J. F. Aitken, A. J. Mathews, K. A. Johnson, R. D. Smith, G. N. Phillips Jr. & J. S. Olson: Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry 1996, 35, 6976-6983.
14. Foster-Nora, J. A. & R. Siden: Amifostine for protection from anti-neoplastic drug toxicity. Amer. J. Health Syst. Pharm. 1997, 54, 787-800.
15. George, P., D. H. Irvine: The reaction between methmyoglobin and hydrogen peroxide. Biochem. J. 1952, 52, 511-517.
16. Grafström, R. C., J. M. Dypbukt, J. C. Willey, K. Sundquist, C. Edman, L. Atzori, C. C. Harris: Pathobiological effects of acrolein in cultured human bronchial epithelial cells. Cancer Res. 1988, 48, 1717-1721.
17. Grossman, R. A., R. W. Hamilton, B. M. Morse, A. S. Penn & M. Goldberg: Nontraumatic rhabdomyolysis and acute renal failure. New Engl. J. Med. 1974, 29, 807-811.
18. Guidet, B. & S. Y. Shah: Enhanced in vivo H2O2 generation by rat kidney in glycerol-induced renal failure. Amer. J. Physiol. 1989, 257, F440-445.
19. Hasanoǧlu, E., Ö. Uluoǧlu & Z. S. Ercan: The protective effects of Iloprost and thromboxane synthetase inhibitor, UK 38485, against glycerol-induced acute renal failure in rats. Leukot. Fatty Acids 1991, 43, 99-102.
20. Ishizuka, S., T. Yano, K. Hagiwara, M. Sone, H. Nihei, H. Ozasa & S. Horikawa: Extracellular signal-regulated kinase mediates renal regeneration in rats with myoglobinuric acute renal injury. Biochem. Biophys. Res. Commun. 1999, 254, 88-92.
21. Johnsson, A. & J. Wennerberg: Amifostine as a protector against cisplatin-induced toxicity in nude mice. Acta Oncol. 1999, 38, 247-253.
22. Karam, H., P. Bruneval, J. P. Clozel, B. M. Loffler, J. Bariety & M. Cloze: Role of endothelin in acute renal failure due to rhabdomyolysis in rats. J. Pharmacol. Exp. Therap. 1995, 274, 481-486.
23. Khan, S., M. Kayahara, U. Joashi, N. D. Mazarakis, C. Sarraf, A. D. Edwards, M. N. Hughes & H. Mehmet: Differential induction of apoptosis in Swiss 3T3 cells by nitric oxide and the nitrosonium cation. J. Cell. Sci. 1997, 110, 2315-2322.
24. Kumar, K. S., V. K. Singh, W. Jackson & T. M. Seed: Inhibition of LPS-induced nitric oxide production in RAW cells by radioprotective thiols. Exp. Mol. Pathol. 2003, 74, 68-73.
25. Lewis, C.: A review of the use of chemoprotectants in cancer chemotherapy. Drug Saf. 1994, 11, 153-162.
26. Longoni, B., M. Migliori, A. Ferretti, N. Origlia, V. Panichi, U. Boggi, C. Filippi, M. G. Cuttano, L. Giovannini & F. Mosca: Melatonin prevents cyclosporine-induced nephrotoxicity in isolated and perfused rat kidney. Free. Radic. Res. 2002, 36, 57-63.
27. Mandal, A. K., J. B. Davis Jr., R. D. Bell & J. M. Miller: Myoglobinuria exacerbates ischemic renal damage in the dog. Nephron 1989, 53, 261-267.
28. Meier, T. & R. D. Issels: Degradation of 2-(3-aminopropylamino)- ethanethiol (WR-1065) by Cu-dependent amine oxidases and influence on glutathione status of Chinese hamster ovary cells. Biochem. Pharmacol. 1995, 50, 489-496.
29. Moncada, S., R. M. Palmer & E. A. Higgs: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43, 109-142.
30. Monteiro, H. P. & A. Stern: Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways. Free Radic. Biol. Med. 1996, 21, 323-333.
31. Mundey, R.: Toxicity of thiols and disulphids: involvement of free-radical species. Free Radic. Biol. Med. 1989, 7, 659-673.
32. Nath, K. A., G. Balla, G. M. Vercellotti, J. Balla, H. S. Jacob, M. D. Levitt & M. E. Rosenberg: Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J. Clin. Invest. 1992, 90, 267-270.
33. Oken, D. E., E. M. L. Arce & D. R. Wilson: Glycerol-induced hemoglobinuric acute renal failure in the rat. I. Micropuncture study of the development of oliguria. J. Clin. Invest. 1966, 45, 724-735.
34. Padgett, C. M. & A. R. Whorton: Regulation of cellular thiol redox status by nitric oxide. Cell Biochem. Biophys. 1995, 27, 157-177.
35. Palmer, T. E., S. M. Glaza, B. C. Dickie, R. H. Weltman & K. S. Greenspun: Toxicity studies on the radioprotective agent WR-2721 in CDF1 mice and beagle dogs. Toxicol. Pathol. 1985, 13, 58-65.
36. Ryan, S. V., S. L. Carrithers, S. J. Parkinson, C. Skurk, C. Nuss, P. M. Pooler, C. S. Owen, A. M. Lefer & S. A. Waldman: Hypotensive mechanisms of amifostine. J. Clin. Pharmacol. 1996, 36, 365-373.
37. Schaefer, F., Y. Chen, T. Tsao, P. Nouri & R. Rabkin: Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J. Clin. Invest. 2001, 108, 467-475.
38. Shah, S. V. & P. D. Walker: Reactive oxygen metabolites in toxic acute renal failure. Ren. Fail. 1992, 14, 363-370.
39. Sipahi, E. Y., Z. A. Keskil, M. Erdinç, Y. Nergis, R. K. Türker & Z. S. Ercan: Effect of glycerol on endothelium-derived factors in the vasculature of the rabbit kidney. Clin. Exp. Pharm. Physiol. 2002, 29, 679-683.
40. Stamler, J. S., D. J. Singel & J. Loscalzo: Biochemistry of nitric oxide and its redox-activated forms. Science 1992, 258, 1898-1902.
41. Stracke, S., F. Ernst, D. R. Jehle, R. W. Grunewald, H. Haller, F. Keller & P. M. Jehle: Differentiating and proliferative effects of HGF in renal proximal tubular cells are mediated via different signalling pathways. Nephrol. Dial. Transplant. 1998, 13, 1398-1405.
42. Torasson, M., M. E. Luken, M. Breitenstein, J. A. Krueger & R. E. Biagini. Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart. Toxicology 1989, 56, 107-117.
43. Treskes, M., E. Boven, A. A. Van de Loosdrecht, J. F. A. Wijffels, J. Cloos, G. J. Peters, H. M. Pinedo & A. Van der Vijgh: Effect of the modulating agent WR 2721 on myelotoxicity and antitumor activity in carboplatin-treated mice. Eur. J. Cancer 1994, 30, 183-187.
44. Tsakadzede, N. L., S. Srivastava, S. O. Awe, A. S. O. Adeagbo, A. Bhatnagar & S. E. D'Souza: Acrolein-induced vasomotor responses of rat aorta. Amer. J. Physiol. Heart Circ. Physiol. 2003, 285, H727-H734.
45. Türker, R. K., E. Demirel & Z. S. Ercan: Iloprost preserves kidney function against anoxia. Prostaglandins Leukot. Essent. Fatty Acids 1988, 31, 45-52.
46. Valdivielso, J. M., J. M. Lopez-Novoa, N. Eleno & F. Perez Barriocanal: Role of glomerular nitric oxide in glycerol-induced acute renal failure. Can. J. Physiol. Pharmacol. 2000, 78, 476-482.
47. Venkatachalam, M. A., H. G. Rennke & D. J. Sandström: The vascular basis for acute renal failure in the rat: preglomerular and postglomerular vasoconstriction. Circ. Res. 1976, 38, 267-279.
48. Whisler, R. L., Y. G. Newhouse, L. Beiging, B. K. Karanfilov, M. A. Goyette & K. V. Hackshaw: Regulation of protein kinase enzymatic activity in Jurkat T cells during oxidative stress uncoupled from protein tyrosine kinases: Role of oxidative changes in protein kinase activation requirements and generation of second messengers. Lymphokine. Cytokine. Res. 1994, 13, 399-410.
49. Whiteside, W. M., D. N. Sears, P. R. Young & D. B. Rubin: Properties of selected S-nitrosothiols compared to nitrosylated WR-1065. Radiat. Res. 2002, 157, 578-588.
50. Yuhas, J. M., J. M. Spellman & F. Culo: The role of WR-2721 in radiotherapy and/or chemotherapy. Cancer Clin. Trials 1980, 3, 211-216.
51. Zager, R. A. & C. A. Foerder: Effects of inorganic iron and myoglobin on in vitro proximal tubular lipid peroxidation and cytotoxicity. J. Clin. Invest. 1992, 89, 989-995.